Immune rejection: the immune biology of allogeneic hematopoietic stem cell transplantation (from mice to humans) - Immune Biology of Allogeneic Hematopoietic Stem Cell Transplantation - page 114

[19] Fujisaki J, Wu J, Carlson AL, Silberstein L, Putheti P, Larocca R, et al. In vivo imaging of
Treg cells providing immune privilege to the haematopoietic stem-cell niche. Nature
2011;474:216-9.
[20] Cudkowicz G, Bennett M. Peculiar immunobiology of bone marrow allografts. I. Graft
rejection by irradiated responder mice. J Exp Med 1971;134:83-102.
[21] Dennert G, Anderson CG, Warner J. T killer cells play a role in allogeneic bone marrow
graft rejection but not in hybrid resistance. J Immunol 1985;135:3729-34.
[22] Raff RF, Deeg HJ, Loughran Jr TP, Graham TC, Aprile JA, Sale GE, et al. Characterization
of host cells involved in resistance to marrow grafts in dogs transplanted from unre-
lated DLA-nonidentical donors. Blood 1986;68:861-8.
[23] Murphy WJ, Kumar V, Bennett M. Acute rejection of murine bone marrow allografts by
natural killer cells and T cells. Differences in kinetics and target antigens recognized.
J Exp Med 1987;166:1499-509.
[24] Raff RF, Sandmaier BM, Graham T, Loughran Jr TP, Pettinger M, Storb R. “Resistance”
to unrelated, DLA-nonidentical canine marrow grafts is unrestricted by the major his-
tocompatibility complex. Exp Hematol 1994;22:893-7.
[25] Vallera DA, Taylor PA, Sprent J, Blazar BR. The role of host T cell subsets in bone
marrow rejection directed to isolated major histocompatibility complex class
I versus class II differences of bm1 and bm12 mutant mice. Transplantation
1994;57:249-56.
[26] Haraguchi K, Takahashi T, Matsumoto A, Asai T, Kanda Y, Kurokawa M, et al. Host-
residual invariant NK T cells attenuate graft-versus-host immunity. J Immunol
2005;175:1320-8.
[27] Blazar BR, Taylor PA, Bluestone JA, Vallera DA. Murine gamma/delta-expressing T cells
affect alloengraftment via the recognition of nonclassical major histocompatibility
complex class Ib antigens. Blood 1996;87:4463-72.
[28] Zimmerman ZF, Levy RB. MiHA reactive CD4 and CD8 T-cells effect resistance to
hematopoietic engraftment following reduced intensity conditioning. Am J Transplant
2006;6:2089-98.
[29] Kernan NA, Flomenberg N, Dupont B, O'Reilly RJ. Graft rejection in recipients of T-cell-
depleted HLA-nonidentical marrow transplants for leukemia. Identification of host-
derived antidonor allocytotoxic T lymphocytes. Transplantation 1987;43:842-7.
[30] Nakamura H, Gress RE. Graft rejection by cytolytic T cells. Specificity of the effector
mechanism in the rejection of allogeneic marrow. Transplantation 1990;49:453-8.
[31] Baker MB, Podack ER, Levy RB. Perforin- and Fas-mediated cytotoxic pathways are not
required for allogeneic resistance to bone marrow grafts in mice. Biol Blood Marrow
Transplant 1995;1:69-73.
[32] Graubert TA, Russell JH, Ley TJ. The role of granzyme B in murine models of acute
graft-versus-host disease and graft rejection. Blood 1996;87:1232-7.
[33] Bennett M, Taylor PA, Austin M, Baker MB, Schook LB, Rutherford M, et al. Cytokine
and cytotoxic pathways of NK cell rejection of class I-deficient bone marrow grafts:
influence of mouse colony environment. Int Immunol 1998;10:785-90.
[34] Taylor MA, Chaudhary PM, Klem J, Kumar V, Schatzle JD, Bennett M. Inhibition of the
death receptor pathway by cFLIP confers partial engraftment of MHC class I-defi-
cient stem cells and reduces tumor clearance in perforin-deficient mice. J Immunol
2001;167:4230-7.
[35] Taylor MA, Ward B, Schatzle JD, Bennett M. Perforin- and Fas-dependent mechanisms
of natural killer cell-mediated rejection of incompatible bone marrow cell grafts. Eur J
Immunol 2002;32:793-9.
[36] Scheffold C, Scheffold YC, Cao TM, Gworek J, Shizuru JA. Cytokines and cytotoxic path-
ways in engraftment resistance to purified allogeneic hematopoietic stem cells. Biol
Blood Marrow Transplant 2005;11:1-2.
[37] Zimmerman Z, Jones M, Shatry A, Komatsu M, Mammolenti M, Levy R. Cytolytic path-
ways used by effector cells derived from recipient naïve and memory T cells and natural
killer cells in resistance to allogeneic hematopoietic cell transplantation. Biol Blood
Marrow Transplant 2005;11:957-71.
[38] Hamby K, Trexler A, Pearson TC, Larsen CP, Rigby MR, Kean LS. NK cells rapidly reject
allogeneic bone marrow in the spleen through a perforin- and Ly49D-dependent, but
NKG2D-independent mechanism. Am J Transplant 2007;7:1884-96.
[39] Mattsson J, Ringden O, Storb R. Graft failure after allogeneic hematopoietic cell trans-
plantation. Biol Blood Marrow Transplant 2008;14:165-70.
[40] Weiden PL, Storb R, Slichter S, Warren RP, Sale GE. Effect of six weekly transfusions on
canine marrow grafts: tests for sensitization and abrogation of sensitization by procar-
bazine and antithymocyte serum. J Immunol 1976;117:143-50.
[41] Komatsu M, Mammolenti M, Jones M, Jurecic R, Sayers TJ, Levy RB. Antigen-primed
CD8+ T cells can mediate resistance, preventing allogeneic marrow engraftment in the

116